These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17436343)

  • 1. Antidepressants in children and adolescents--changes in utilisation after safety warnings.
    Dean AJ; Hendy A; McGuire T
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1048-53. PubMed ID: 17436343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of regulatory warnings on antidepressant prescribing for children and adolescents.
    Kurian BT; Ray WA; Arbogast PG; Fuchs DC; Dudley JA; Cooper WO
    Arch Pediatr Adolesc Med; 2007 Jul; 161(7):690-6. PubMed ID: 17606833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of antidepressants among children and adolescents--did the warnings lead to fewer prescriptions?].
    Bramness JG; Engeland A; Furu K
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2653-5. PubMed ID: 17952146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A place for SSRIs in the treatment of severely depressed children and adolescents].
    Roobol TH; Buitelaar JK
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1710-2. PubMed ID: 18727599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.
    Katz LY; Kozyrskyj AL; Prior HJ; Enns MW; Cox BJ; Sareen J
    CMAJ; 2008 Apr; 178(8):1005-11. PubMed ID: 18390943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
    Cheung A; Sacks D; Dewa CS; Pong J; Levitt A
    J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
    Sheffield RE; Lo Sasso AT; Young CH; Way K
    Adm Policy Ment Health; 2002 Nov; 30(2):121-39. PubMed ID: 12680617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
    Volkers AC; Heerdink ER; van Dijk L
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1054-62. PubMed ID: 17551992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
    Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
    JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial.
    Stewart RM; Hood SD; Rao P; Moore JK; Runions KC; Murphy SE; Wong JWY; Zepf FD
    Trials; 2018 Aug; 19(1):434. PubMed ID: 30097056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
    Tandt H; Audenaert K; van Heeringen C
    Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.